1. Introduction {#sec1}
===============

Patients with chronic kidney disease (CKD) often have decreased physical fitness and activity \[[@B1]\]. The main causes are muscle atrophy \[[@B2]\], myopathy \[[@B3]\], inactivity \[[@B4]\], malnutrition \[[@B5]\], and lower albumin levels \[[@B6]\]. Besides, anemia, inflammation, and uremic acidosis also play a role \[[@B7]\].

It was well demonstrated that increased urinary protein and albumin excretion are well-known risk factors for cardiovascular end-organ damage \[[@B8], [@B9]\]. Emerging data suggest that greater physical activity may be associated with less albuminuria and physical activity could protect against albuminuria \[[@B10], [@B11]\]. However, the relationship between physical activity and albuminuria is not uniform. For example, in diabetic patients, physical activity is associated with lower albumin excretion, and physical activity has led to regression of albuminuria in interventional studies \[[@B12], [@B13]\]. However, in nondiabetics these associations were not observed \[[@B14], [@B15]\]. The relationship between physical activity and albumin/protein excretion become more complex by the phenomenon of postexercise proteinuria. Transient proteinuria, including albuminuria, is common after intense exercise, and the prevalence ranges from 18% to 100%, depending on the type and intensity \[[@B16], [@B17]\]. Although all these data exist, there are few studies in the literature which specifically address the level of kidney function, urinary albumin excretion, and daily physical activity. Thus the current study was aimed to investigate the relationship between daily physical activity, kidney function, and urinary albumin excretion.

2. Methods {#sec2}
==========

The subjects for this cross-sectional investigation were patients attending to the nephrology outpatient clinic in a state hospital for the first time or who are under followup. The study was in accordance with the Declaration of Helsinki and local approval and written informed consent was obtained from all patients. The demographic characteristics including age, sex, smoking status (smoker or nonsmoker), and clinical characteristics (presence of diabetes mellitus, presence of coronary artery disease, and the medications used) were recorded. The exclusion criteria were as follows: type 1 diabetes, cerebrovascular disease, amputation history, presence of rhythm problems, uncontrolled hypertension, hyper- and hypothyroidism, chronic liver disease, regular analgesic use, symptomatic heart failure, fracture history, and a history of physical activity apart from normal daily activities in the last 24 hours. None of the patients were taking steroids and immunosuppressants during the study period.

All patients underwent routine physical examination; blood pressure (BP) measurements and 12-lead ECG and laboratory analysis. Office BP measurements were performed using a mercury sphygmomanometer. Adequately sized cuffs (standard cuff of 23 × 12 cm or a large cuff of 34 × 15 cm) according to arm circumference were placed on the nondominant arm. The first and fifth phases of Korotkoff sounds were taken as the systolic and diastolic BP, respectively. The measurements were taken after the patients had rested for 10 min in the sitting position with the arm comfortably placed at the heart level. Two measurements were taken at 5 min intervals. Each set of two measurements was averaged to give the office systolic and diastolic BPs.

Routine biochemical analysis and 24-hour urine specimens were collected to determine creatinine clearance as well as protein and albumin excretion. An information leaflet along with a urine container was given to all subjects and they also received a verbal explanation about how to collect a proper 24-hour urine sample. After excluding the first morning urine sample of the collection day, urine was collected over 24 h, which included the first urine sample of the next morning. At the end of the collection period, the urine containers were taken to the laboratory within 2--4 h. Adequacy of urine collection was determined by the predetermined standards \[[@B18]\]. Insulin resistance was calculated in diabetic patients by homeostasis model assessment (HOMA-INDEX) by the following formula: $$\begin{matrix}
{\left( \text{HOMA-INDEX} \right):} \\
\left\lbrack {\text{fasting}{\,\,}\text{plasma}{\,\,}\text{glucose}\left( {\text{in}{\,\,}\text{millimoles}{\,\,}\text{per}{\,\,}\text{liter}} \right)} \right. \\
\left. {  \times \text{fasting}{\,\,}\text{serum}{\,\,}\text{insulin}\left( {\text{in}{\,\,}\text{microunits}{\,\,}\text{per}{\,\,}\text{milliliter}} \right)} \right\rbrack \\
{\quad \times \left( 22.5 \right)^{- 1}.} \\
\end{matrix}$$

After being given an explanation measurement of daily activities using Nottingham Extended Activities of Daily Living Scale (NEADLS) which was performed for each patient in interview. The NEADLS was originally designed in the UK, and it is also one of the most popular extended activities of daily living scales in rehabilitation centers \[[@B19]\]. Responses to all questions are evaluated as not performed, 0 point; with help, 1 point; on my own with difficulty, 2 points; on my own easily, 3 points. For each subsection total, and with summation of all scores, final total NEADLS scores are obtained, and they range between 0 and 66 points \[[@B19]\].

2.1. Statistical Analysis {#sec2.1}
-------------------------

All values are expressed as mean ± standard deviation. Data were analyzed using the program SPSS 15.0 for Windows (SPSS, Inc., Chicago, IL). *P* \< 0.05 was accepted as statistically significant. Correlations were analyzed by Pearson correlation coefficient *r* if the variables are distributed normally. Spearman\'s correlation coefficient rho was used if the variables are not distributed normally. Analysis of NEADLS score according to CKD stages was carried out by Kruskal-Wallis Test. For the post hoc analysis of groups Bonferroni corrected Mann-Whitney *U* test was performed. Stepwise multiple linear regression was performed to identify independent variables (age, gender, body mass index, presence of diabetes, presence of coronary artery disease, hemoglobin, albumin, 24-hour urinary albumin excretion (UAE), and 24-hour creatinine clearance) related to logarithmically converted NEADLS score (as a dependent variable).

3. Results {#sec3}
==========

Initially 173 patients were enrolled. Two patients with type 1 diabetes, 3 patients with cerebrovascular disease, 1 patient with amputation, 4 patients with rhythm problems, 2 patients with uncontrolled hypertension with 1 patient with hyperthyroidism, 2 patients with hypothyroidism, 2 patients with chronic liver disease, 7 patients with regular analgesic use, 2 patients with symptomatic heart failure, 3 patients with fracture history, and 5 patients with a history of physical activity apart from normal daily activities in the last 24 hours were excluded. Thus the final population included 139 patients. The demographic characteristics of the patients were given in [Table 1](#tab1){ref-type="table"}. Twenty-nine patients had normal renal function, 20 patients have stage 1 CKD (defined as creatinine clearance \>90 mL/min/1.73 m^2^) but have proteinuria/albuminuria and/or renal structural damage, 29 patients have stage 2 CKD (defined as creatinine clearance between 60 and 89 min/1.73 m^2^), 49 patients have stage 3 CKD (defined as creatinine clearance between 30 and 59 min/1.73 m^2^), 5 patients have stage 4 CKD (defined as creatinine clearance between 15 and 29 min/1.73 m^2^), and 7 patients have stage 5 CKD (defined as creatinine \<15 min/1.73 m^2^). The laboratory parameters of the patients were shown in [Table 2](#tab2){ref-type="table"}.

In whole group NEADLS score was correlated with age (rho: −0.759, *P* \< 0.0001), clinical SBP (rho: −0.212, *P*: 0.018), blood urea nitrogen (rho: −0.516, *P* \< 0.0001), creatinine (rho: −0.501, *P* \< 0.0001), uric acid (rho: −0.308, *P* \< 0.0001), albumin (rho: 0.382, *P* \< 0.0001), total cholesterol (rho: −0.194, *P*: 0.022), LDL-cholesterol (rho: −0.230, *P*: 0.008), hemoglobin (rho: 0.256, *P*: 0.002), creatinine clearance (rho: 0.565, *P* \< 0.0001), 24-hour urinary protein excretion (rho: −0.324, *P* \< 0.0001), and 24-hour UAE (rho: −0.483, *P* \< 0.0001).

Scatter plot graphic between logarithmically converted NEADLS score with logarithmically converted 24-hour urinary albumin excretion and 24-hour creatinine clearance was shown in Figures [1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}, respectively.

Comparison of NEADLS scores among patients with normal renal function and CKD stages were shown in [Table 3](#tab3){ref-type="table"}.

Subgroup analysis in 57 diabetic patients has shown that NEADLS score was correlated with age (rho: −0.601, *P* \< 0.0001), blood urea nitrogen (rho: −0.401, *P*: 0.002), creatinine (rho: −0.471, *P* \< 0.0001), creatinine clearance (rho: 0.502, *P* \< 0.0001), albumin (rho: 0.413, *P*: 0.001), 24-hour urinary protein excretion (rho: −0.438, *P*: 0.001), and 24-hour urinary albumin excretion (rho: −0.466, *P* \< 0.0001). However, there was no relationship with HbA1c and insulin levels and HOMA-Index among diabetic patients. Intact parathyroid hormone (PTH) levels were available for 75 patients. In these group of patients NEADLS score was negatively associated with intact PTH levels (rho: −0.416, *P* \< 0.0001).

Then multivariate linear regression of independent factors including age, gender, body mass index, presence of diabetes, presence of coronary artery disease, hemoglobin, albumin, 24-hour UAE, and 24-hour creatinine clearance related to logarithmically converted NEADLS score (as a dependent variable) was carried out. Of note 24-hour urinary protein excretion was not put into model due to high colinearity with 24-hour UAE. The results of the linear regression were shown in [Table 4](#tab4){ref-type="table"}.

4. Discussion {#sec4}
=============

The current study investigated the independent relationship between daily physical activity with creatinine clearance and 24-hour UAE. As a result it was demonstrated that 24-hour creatinine clearance was positively and 24-hour UAE was negatively corelated with daily activity. These findings are novel since very few studies examined the relationship between 24-hour creatinine clearance and 24-hour UAE with daily physical activity in a simultaneous way.

Recently, it was realized that both albuminuria and low glomerular filtration rate predict accelerated loss of kidney function, end-stage kidney failure, cardiovascular morbidity, and mortality \[[@B20]--[@B22]\]. The current study also showed that both increased UAE and decreased creatinine clearance are independently corelated with physical activity. Thus apart from cardiovascular risk, physical activity was also influenced both by UAE and creatinine clearance.

Previously, it was suggested that greater physical activity may be associated with less urinary albumin excretion. One of the mechanisms of this finding may be the endothelial dysfunction. Indeed, it was demonstrated that physical activity has protective effects on the vascular endothelium and endothelial dysfunction in the renal vasculature is associated with albuminuria \[[@B10]\]. Thus the relationship between increased albumin excretion and decreased physical activity may be explained in the context of endothelial dysfunction. Unfortunately, in the current study the endothelial dysfunction was not measured. Another explanation may be the presence of microangiopathy and atherosclerosis \[[@B24], [@B25]\]. Besides, increased UAE---as a measure of microangiopathy---has been suggested to influence lower limp function \[[@B23]\]. It has also been suggested that atherosclerosis through chronic ischemia may lead to a disturbance of bone remodeling and to a loss of the mechanical properties of the bone \[[@B26], [@B27]\] which may lead to decreased activity. Thus the association between UAE and decreased physical activity might reflect this relationship. Last but not the least, increased oxidative stress and inflammation may be potential explanations regarding the relationship between increased UAE and decreased physical activity. Indeed, it was demonstrated that physical exercise reduces both oxidative stress and inflammation \[[@B28]--[@B30]\], which are both related with albuminuria.

In the present study daily physical activity was positively correlated with creatinine clearance. Indeed, previous studies have shown that habitual physical activity was positively associated with renal function \[[@B31]--[@B33]\]. Why decrease in creatinine clearance was associated with decreased physical activity? Currently the exact mechanisms are unknown but speculations can be made. It is possible that progression of neuropathy by decreasing kidney function may contribute to a reduction in muscle mass with a consequent impact on mobility and physical activity. Another explanation may be the reduced bone mass. Although not universal, some studies have shown that subjects with mild to moderate CKD may have increased risk of osteoporosis \[[@B34]\]. Also other bone abnormalities seen in CKD such as osteitis fibrosa or adynamic bone disease may result in diminished physical activity. In the current study in a subgroup of patients with intact PTH levels being available, a negative association between intact PTH and NEADLS score was found. Thus more studies are needed to highlight specific relationship between PTH, bone histology, and physical activity in CKD patients.

Inflammation, acidosis, protein-energy malnutrition which are common in CKD patients may be other potential explanations given the fact that these conditions are aggravated with sedentary life and active daily life has vasculoprotective effects \[[@B7], [@B35], [@B36]\].

The findings of the current study may have potential implications. As an example it would be interesting to test whether drugs that decreased albumin excretion will also improve physical activity. On the other hand it should be determined whether increasing daily activity will improve kidney function.

The present study has some limitations that deserve mention. As the study was cross-sectional temporality cannot be suggested. Besides the current findings might be interpreted with caution since associations may be 2-sided. On one hand it could be possible that patients who were physically active may have lower albuminuria values and better renal function. On the other hand, that patients with a better renal function (not severe renal disease) practice regular physical activity more easily than patients with more severe renal damage. Thus cause and effect relationship cannot be suggested in such a kind of study.

Second, despite multivariate adjustment for multiple potential confounders, there remains a possibility of residual confounding. Given the fact that change in albumin excretion may occur even in the same individual, only one measurement of UAE is another limitation. Because physical activity can induce a transient increase in UAE, the association between regular physical activity and albuminuria can be difficult to study \[[@B16]\]. However, the patients with history of exercise apart from normal daily activity in the last 24 hours were excluded in the study. The current study also did not evaluate inflammation level and acidosis and alkalosis level.

In conclusion, daily physical activity is independently corelated with both UAE and kidney function. Studies are needed to highlight underlying mechanisms.

![The scatter plot graph between logarithmically converted Nottingham Extended Activities of Daily Living Scale (NEADLS) score and logarithmically converted 24-hour urinary albumin excretion (UAE).](IJN2013-248416.001){#fig1}

![The scatter plot graph between logarithmically converted Nottingham Extended Activities of Daily Living Scale (NEADLS) score and 24 hour creatinine clearance.](IJN2013-248416.002){#fig2}

###### 

The demographic and clinical parameters of 139 patients.

  Variable                                                        
  -------------------------------------------------------------- --------------
  Age (years) (mean ± SD)                                        52.6 ± 15.7
  Sex (male/female) (*n*:)                                       67/72
  BMI (kg/m^2^) (mean ± SD)                                      28.9 ± 5.9
  Type 2 diabetes (present/absent) (*n*:)                        57/82
  Smoking (present/absent) (*n*:)                                30/109
  Presence of CAD (*n*:)                                         18/121
  Use of ACE inhibitor (present/absent) (*n*:)                   27/112
  Use of calcium channel blocker (CCB) (present/absent) (*n*:)   27/112
  Use of *β*-blocker (present/absent) (*n*:)                     25/114
  Use of *α*-blocker (present/absent) (*n*:)                     4/135
  Use of diuretic (present/absent) (*n*:)                        21/118
  Use of AT2 blocker (present/absent) (*n*:)                     37/102
  Use of spironolactone (present/absent) (*n*:)                  8/131
  Office systolic blood pressure (SBP) (mmHg) (mean ± SD)        132.3 ± 16.9
  Office DBP (mmHg) (mean ± SD)                                  81.15 ± 9.8

SD: standard deviation; BMI: body mass index; CAD: coronary artery disease; ACE: angiotensin converting enzyme; CCB: calcium channel blocker; *β*: beta-Adrenergic; *α*: alpha-adrenergic; AT2: angiotensin receptor blocker; SBP: systolic blood pressure; DBP: diastolic blood pressure.

###### 

The laboratory parameters of 139 patients.

  Variable                                      
  -------------------------------------------- ----------------
  Fasting blood glucose (mmol/L)               6.72 ± 2.70
  Blood urea nitrogen (mmol/L)                 8.14 ± 5.28
  Creatinine (*µ*mol/L)                        121.1 ± 73.4
  Sodium (mmol/L)                              140.3 ± 3.5
  Potassium (mmol/L)                           4.60 ± 0.57
  Calcium (mmol/L)                             2.35 ± 0.15
  Phosphorus (mmol/L)                          1.16 ± 0.21
  Uric acid (*μ*mol/L)                         342.6 ± 117.8
  Albumin (g/L)                                42.2 ± 4.7
  Total cholesterol (mmol/L)                   4.83 ± 1.15
  LDL-cholesterol (mmol/L)                     2.90 ± 0.87
  HDL-cholesterol (mmol/L)                     1.17 ± 0.29
  Triglyceride (mmol/L)                        1.84 ± 1.08
  TSH (mU/L)                                   2.13 ± 1.30
  Hemoglobin (g/L)                             132.2 ± 16.5
  Creatinine clearance (mL/min)/1.73 m^2^      75.3 ± 39.4
  24-hour urinary protein excretion (mg/day)   641.1 ± 1019.1
  24-hour urinary albumin excretion (mg/day)   116.0 ± 234.1

Data are mean ± SD except when stated otherwise ALT: alanine aminotransferase; AST: aspartate aminotransferase; LDL: low-density lipoprotein; HDL: high-density lipoprotein, TSH: thyroid stimulating hormone; T3: triiodothyronine; T4: thyroxine.

###### 

Comparison of NEADLS scores among patients with normal renal function and CKD.

  NEADLS score                                                 *P* for trend
  --------------------------------- -------------------------- ---------------
  Normal renal function (group 1)   42.9 ± 15.8^III,IV,V,VI^   \<0.0001
  Stage 1 CKD (group 2)             36.3 ± 14.8^IV,V,VI^       
  Stage 2 CKD (group 3)             25.9 ± 13.5^I^             
  Stage 3 CKD (group 4)             23.4 ± 13.6^I,II^          
  Stage 4 CKD (group 5)             13.2 ± 5.5^I,II^           
  Stage 5 CKD (group 6)             15.4 ± 4.0^I,II^           

*P* value is based on Kruskal-Wallis test (groups with significant differences according to the post hoc testing are shown in superscript numbers).

###### 

Results of linear regression of independent factors corelated with Nottingham Extended Activities of Daily Living Scale score.

                                        *β*      Beta     95% CI             *P*
  ------------------------------------- -------- -------- ------------------ ----------
  Age                                   −0.010   −0.589   −0.013--(−0.008)   \<0.0001
  Being female                          0.013    0.025    0.040--0.066       0.638
  Presence of diabetes                  0.022    0.043    −0.032--0.076      0.415
  Presence of coronary artery disease   −0.101   −0.134   −0.178--(−0.024)   0.011
  Body mass index                       0.001    0.006    −0.004--0.005      0.910
  Hemoglobin                            0.020    0.128    0.003−0.037        0.020
  Albumin                               0.042    0.076    −0.017--0.101      0.166
  24-hour creatinine clearance          0.002    0.163    0.001--0.007       0.004
  24-hour urinary albumin excretion     −0.021   −304     −0.032--(−0.010)   \<0.0001

*β*: Partial regression coefficient; Beta: partial correlation coefficient.
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